The US FDA Approves a New Drug to Prevent RSV in Babies and Toddlers

The US FDA has approved a new drug to prevent RSV in babies and toddlers. If you look at the clinical trials for this product from AstraZeneca, you can see it says no results found. This is an investigative product. This is still under clinical trial. So I just want parents to be aware of what might be sneaked into their child's vaccination program or as a newborn baby. Are they receiving a monoclonal antibody for a condition that they don't need to have it? That's my warning for parents.